This is a patient with severe atopic dermatitis, treated with multiple topicals including topical steroids, topical calcineurin inhibitors and Eucrisa. The provider is requesting Dupixent. The health plan's determination is upheld. The standard treatment options for patients with atopic dermatitis include a regimen of topical steroids as well as topical calcineurin inhibitors. After topical agents fail, standard practice is to pursue systemic therapy such as phototherapy.Since the documentation does not support that the patient has tried and failed phototherapy or a systemic immunosuppressant and does not have a contraindication to these, the requested Dupixent is not medically necessary..

1) Mennini M, Dahdah L, Fiocchi A. "Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis." N Engl J Med. 2017 Mar 16;376(11):1090. 2) Simpson EL et al. "Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes: A phase IIb randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis." J Am Acad Dermatol. 2016 Sep;75(3):506-515. 3) Han Y et al. "Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials." J Allergy Clin Immunol. 2017 May 4. 4) Blauvelt A et al. "Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial." Lancet. 2017 May 4. pii: S0140-6736(17)31191-1. 5) Kraft M, Worm M. "Dupilumab in the treatment of moderate-to-severe atopic dermatitis." Expert Rev Clin Immunol. 2017 Apr;13(4):301-310. 6) Cork MJ et al. "Pharmacokinetics, safety, and efficacy of Dupilumab in a pediatric population with moderate-to-severe atopic dermatitis: results from an open-label phase 2a trial." Not yet published. 7) Sidbury R et al. "Guidelines of care for the management of atopic dermatitis. Section 4. Prevention of disease flares and use of adjunctive therapies and approaches." J Am Acad Dermatol 2014;71:1218-33. 8) Simpson EL et al. "When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council." J Am Acad Dermatol. 2017 Oct;77(4):623-633. 9) Sidbury R et al. "Guidelines of care for the management of atopic dermatitis." J Am Acad Dermatol. 2018. 10) Wollenberg A et al. "Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II." J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878.4 Dec;71(6):1218-33.